Swedish Life Sciences Stock News

Hoist Finance (OM:HOFI) delivered earnings that are forecast to grow at 15% per year, outpacing the Swedish market's 12.6% growth expectation. Revenue is projected to rise by 11.8% per year, handily beating the broader market's 3.9% average, and profit margins remain stable at 20.2%. Investors are watching as continued profit and revenue growth, alongside attractive valuation, set the stage for the company’s outlook this earnings season. See our full analysis for Hoist Finance. Next, we will...

Exsitec Holding (OM:EXS) reported forecasted revenue growth of 7.6% per year, outpacing the Swedish market average of 3.9%. EPS growth is even more striking, with projections at 19.87% per year versus the local market’s 12.6%. However, recent net profit margins narrowed to 7% from last year’s 10.2%. Shares are trading at SEK160, which is below the estimated fair value of SEK234.59, despite carrying a higher Price-to-Earnings Ratio (35.9x) than both sector and peer averages. In the longer...

Saab (OM:SAAB B) posted earnings margins of 7.4%, an increase from 6.4% last year, and reported robust 42.6% growth in earnings over the past year, well ahead of its five-year average of 30.7% per year. Looking ahead, the company expects annual earnings growth of 17.8% and revenue growth of 14.3%, both outpacing the broader Swedish market’s projected rates. Investors are watching these improved profit margins and sustained earnings momentum as positive indicators, while staying mindful of...

Billerud (OM:BILL) posted net profit margins of 2.8%, up from last year's 1.5%, with earnings growth of 98.5% over the past twelve months. This marks a sharp turnaround from a five-year annual decline of 0.6%. While revenue is projected to inch up 1% per year, which trails the Swedish market's expected 3.9%, the company forecasts a robust 40.6% annual rise in earnings, outpacing the market’s 12.6% rate. Investors will be focused on whether this accelerating profitability can sustain the...

Storskogen Group AB (publ)'s ( STO:STOR B ) price-to-sales (or "P/S") ratio of 0.5x may look like a pretty appealing...

With a median price-to-sales (or "P/S") ratio of close to 0.4x in the Healthcare industry in Sweden, you could be...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Instalco (OM:INSTAL) is forecasting earnings growth of 27.91% per year, outpacing the Swedish market, with revenue set to expand by 6.4% annually. Despite these strong growth projections, the company’s net profit margins have slipped to 2% from last year’s 3.9%, and earnings have declined by 4.3% per year over the past five years. Shares are currently trading at SEK24.82, notably below the estimated fair value of SEK70.33. Instalco also commands a higher Price-to-Earnings ratio than its...

Orexo (OM:ORX) remains unprofitable, with losses increasing at an average rate of 3.7% per year over the past five years. Revenue is forecast to grow by 2.5% annually, trailing behind the broader Swedish market’s 3.9% average growth. While the company’s slower growth and ongoing losses present real challenges for investors, the current Price-To-Sales Ratio of 1.8x stands out as a notable value play within the European pharmaceuticals sector. See our full analysis for Orexo. Next up, we’ll see...

Bufab (OM:BUFAB) posted a standout year, growing earnings by 27.9% annually, well ahead of its five-year average of 10.5%. Net profit margins reached 7.4%, up from 5.6% last year. Revenue is now projected to rise 7% per year, outpacing the Swedish market’s 3.9% annual forecast. With EPS growth set to beat sector averages and high-quality earnings recognized, investor focus is turning to Bufab’s accelerating profit growth and widening margins as key strengths. See our full analysis for...

Vertiseit (OM:VERT B) is forecasting robust earnings growth of 44.6% per year, significantly ahead of the Swedish market's expected 12.6% pace. Revenue is projected to climb 6.2% annually, outperforming the broader market’s 3.9% rate. Shares currently trade just below their estimated fair value at SEK69.8. Despite the strong top-line and earnings forecasts, net profit margin has narrowed to 1.8% from 9.3% last year. This highlights recent margin pressure, which will be key for investors...

Volvo Car AB (publ.) (OM:VOLCAR B) stock jumped more than 30% to its highest level in 15 months after the company reported third-quarter profits that exceeded expectations, driven by rapid cost-cutting and operational improvements. See our latest analysis for Volvo Car AB (publ.). Volvo Car AB (publ.)’s recent surge reflects more than just a strong quarter. The stock’s remarkable 47% share price return in the past week is part of a broader rebound, with year-to-date gains of 34%. This...

Sedana Medical (OM:SEDANA) continues to operate at a loss, with net losses deepening at a steady rate of 1% per year over the last five years and ongoing forecasts pointing to unprofitability for at least the next three years. Meanwhile, revenue is expected to grow an impressive 26.45% per year, well outpacing the Swedish market average of 3.9% each year. This makes strong sales growth the central reward for investors weighing the company’s persistent challenges in reaching profitability. See...

Prevas (OM:PREV B) is forecast to deliver revenue growth of 5.7% per year and a robust 29.3% annual expansion in EPS, both outpacing the Swedish market averages of 3.9% and 12.6% respectively. Despite an 8.3% per year earnings growth over the past five years and favorable valuation multiples, recent profitability has come under pressure. The net profit margin fell to 4% from last year's 7.4%, and a one-off SEK29.3 million loss weighed on the latest results. Even so, investors are likely to...

CTT Systems (OM:CTT) has delivered a 28.7% annual earnings growth rate over the past five years, a trend underpinned by high quality results. Current net profit margins stand at 20%, down from last year’s 32.1%. The forecast for revenue growth sits at a robust 23.4% per year, outpacing both the Swedish market and industry peers. With a current share price of SEK193, which is notably above the estimated fair value of SEK127.27 and the industry average Price-To-Earnings ratio, the company’s...

Idun Industrier (OM:IDUN B) delivered a standout year, with earnings surging 33.2% and profit margins improving to 1.9% from 1.4%. This performance easily topped the company’s five-year average annual earnings growth rate of 20.2%. Future guidance points to continued, if more moderate, expansion with earnings expected to rise 10.9% per year. With revenue projected to outpace the wider Swedish market, these results set a strong tone for investors considering the company’s growth story. See our...

Cint Group (OM:CINT) just turned the corner to profitability, buoyed by a large one-off gain of €2.3 million that lifted earnings over the past 12 months. Looking ahead, earnings are forecast to grow 35.2% per year, with revenue expected to climb 4.3% annually. Both metrics are expected to outpace the broader Swedish market. While the company’s five-year average earnings growth has been negative at -33.7% per year, recent momentum and a share price of SEK4.33 put the focus squarely on Cint’s...

Evolution (OM:EVO) made headlines after releasing its third quarter results, which saw both revenue and net income decline from last year. At the same time, the company escalated litigation by formally adding Playtech as a defendant. See our latest analysis for Evolution. Even before this week’s legal escalation, Evolution’s stock had been under pressure as market sentiment shifted. The 30-day share price return stands at -17.89 percent, with the total shareholder return over the past year...

Beijer Ref (OM:BEIJ B) reported that net profit margins narrowed to 6.4% from 7.3% in the most recent period. After five years of average yearly earnings growth at 27.8%, the latest results show a negative earnings trend. Investors are weighing these figures against ongoing forecasts for approximately 13% annual earnings growth and 5.8% revenue growth, both of which are set to outpace the Swedish market. See our full analysis for Beijer Ref. Next up, we will examine how these results compare...

Wondering what to do with Röko stock right now? You are not alone. The share price just closed at 1900.0, and if you have been watching closely, you have probably noticed a blend of cautious optimism and uncertainty in the recent numbers. Over the last week, Röko edged up by 1.8%, bouncing back a little from a tricky stretch that saw it fall by 4.6% over the past month. For those who have held on since the start of the year, it has been a tough ride, with the stock down 11.9%...

AFRY (OM:AFRY) is forecasting earnings growth of 30.3% per year, far outpacing the Swedish market’s average of 12.6% and the company's own projected revenue growth rate of 4.9%. Net profit margins currently sit at 3.6%, down from last year’s 4.4%, while earnings have averaged 4.1% growth per year over the last five years. With shares trading at a Price-to-Earnings ratio of 20.7x, which is above its peer average but in line with the broader industry, investors are weighing the company’s high...

Beijer Alma (OM:BEIA B) posted a net profit margin of 8.9%, up from 7.6% last year, with EPS growth increasing by 23.2% over the past year, more than doubling its five-year average of 9.8% per year. Looking ahead, the company’s earnings are forecast to expand by 20.3% per year and revenue by 4.8% per year, both outperforming Swedish market norms. Momentum is building behind Beijer Alma, with accelerating profit growth and widening margins setting an optimistic tone for investors considering...

Bravida Holding (OM:BRAV) posted annual revenue growth of 4.6%, topping the Swedish market’s expected pace of 3.9% per year. Annual earnings are forecast to rise around 12% per year, just below the Swedish market’s projected 12.6%. Profit margins edged higher to 3.9% from 3.7% last year. The data highlights recent revenue expansion, improving margins, and a mixed valuation sentiment with shares trading at SEK84.5, significantly below analyst fair value estimates. See our full analysis for...

AB Sagax (OM:SAGA A) posted a striking surge in profitability, with earnings up 101.5% over the last year after a run of average annual declines of 17.2% over the past five years. Net profit margins climbed to 87.1% from 48.8%, as a SEK1.2 billion one-off gain played a big role in the past twelve months’ results. With such a significant non-recurring boost to earnings, investors will need to weigh whether these headline figures signal true momentum or just a temporary upside. See our full...